Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Stolz, W. Boersma, R. Louis, F. Blasi, B. Milenkovic, A. Lacoma, J. Aerts, V. Heinen, M. Pappalettera, K. Kostikas, C. Prat, E. Wouters, A. Torres, T. Welte, M. Tamm (Basel, Switzerland; Alkmaar, Breda, Maastricht, Netherlands; Liege, Belgium; Milan, Italy; Serbia, Republic Of Serbia; Badalona, Barcelona, Spain; Larissa, Greece; Hannover, Germany). Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD. Eur Respir J 2011; 38: Suppl. 55, 403

Member's Comments

No comment yet.

Related content which might interest you: Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Physical activity (PA) levels during recovery from severe acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease Year: 2014 Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Effect of exercise challenge on systemic inflammatory markers in healthy smokers and smokers with COPD Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease Year: 2014 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Relationship between emergency admission and exercise capacity in patients with COPD Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014